Research in head and neck cancer
We are always learning more about cancer. Researchers and healthcare professionals use what they learn from research studies to develop better ways to treat head and neck cancer. The following is a selection of research showing promise for treating head and neck cancer.
We’ve included information from the following sources. Each item has an identity number that links to a brief overview (abstract).
- PubMed, US National Library of Medicine (PMID)
- Canadian Cancer Trials and ClinicalTrials.gov (NCT)
Researchers are looking for the best ways to treat head and neck cancer using surgery. They want to find new ways of doing surgery that cause less injury to the body (called minimally invasive surgery) and fewer problems (complications).
Transoral robotic surgery and transoral laser microsurgery use either a
surgical robot or a laser with an
Radiation therapy @(Model.HeadingTag)>
Researchers are looking for ways to improve radiation therapy as a treatment for head and neck cancer.
Proton therapy is a type of
Stereotactic body radiation therapy (SBRT) delivers precisely targeted high doses
of radiation to tumours in difficult or hard-to-reach areas in fewer sessions than
standard external radiation therapy. It lowers the harmful effects (toxicities) of
radiation on healthy tissue. Researchers are looking at using SBRT to give radiation
again (reirradiation) for head and neck cancer that has come back after standard
external radiation therapy. Early studies show SRBT may be help control the cancer and
improve survival, but
The following is noteworthy research in chemotherapy for head and neck cancer.
Induction chemotherapy is given as the first treatment and followed by other
treatments. Researchers are trying to find out if induction chemotherapy followed by
Metronomic chemotherapy gives smaller doses of a drug over a longer period of time, which can help lower side effects while controlling the cancer. Researchers are studying metronomic chemotherapy for head and neck cancer that has come back after treatment. Research shows that metronomic chemotherapy may be a treatment option for advanced head and neck cancer, especially when other treatments haven’t worked (Indian Journal of Cancer, PMID 29199656; Medicine, PMID 28403082).
New chemotherapy drugs that show promise in treating head and neck cancer include:
Immunotherapy helps to strengthen or restore the immune system’s ability to fight cancer. Researchers are studying the following types of immunotherapy for head and neck cancer.
Immune checkpoint inhibitors are types of immunotherapy drugs called
Targeted therapy @(Model.HeadingTag)>
Targeted therapy drugs target specific molecules (usually proteins) that cause cancer cells to grow. The following targeted therapy drugs are showing promise in treating head and neck cancer.
PI3K (phosphoinositide 3-kinase) inhibitors work by switching off PI3K, which is an
mTOR inhibitors work by blocking mTOR, which is a protein that regulates cellular metabolism and growth and how quickly cells multiply. Researchers are looking at the following mTOR inhibitors for treating head and neck cancer:
- everolimus (Afinitor) (Head and Neck, PMID 27232378; Annals of Oncology, PMID 26025965)
- temsirolimus (Torisel) (Annals of Oncology, PMID 28961834, PMID 25527417)
Tyrosine kinase inhibitors are drugs that block the enzyme tyrosine kinase, which helps cells develop and grow. Researchers are looking at the following tyrosine kinase inhibitors in treating head and neck cancer:
- afatinib (Giotrif) (Annals of Oncology, PMID 27084954; Oral Oncology, PMID 26705063)
- dacomitinib (Vizimpro) (Expert Opinion on Investigational Drugs, PMID 2700370; American Journal of Clinical Oncology, PMID 26967327)
- erlotinib (Tarceva) (Head and Neck, PMID 26918562; Clinical Oral Investigations, PMID 26297130)
- gefitinib (Iressa) (Cancer Biology and Therapy, PMID 25756517; Head and Neck, PMID 24585506)
- lapatinib (Tykerb) (Journal of Clinical Oncology, PMID 26527790)
Monoclonal antibodies block a target (often a protein) on the outside of a cancer cell. They do this by recognizing and locking onto the protein so that it can’t do its job. Panitumumab (Vectibix) is a monoclonal antibody that attaches to epidermal growth factor receptor (EGFR) proteins on cancer cells. Researchers are looking at panitumumab as a treatment for head and neck cancer (The Oncologist, PMID 28592616; European Journal of Cancer, PMID 28040660).
Other treatments @(Model.HeadingTag)>
Researchers are looking at the following as possible treatments for head and neck cancer.
Photodynamic therapy (PDT) destroys cancer cells using a drug called a photosensitizer, which makes them very sensitive to laser light. The laser light sources usually can’t pass through more than a few millimetres of tissue, so PDT is mainly used to treat areas on or just under the skin, or in the lining of some internal organs. Researchers are studying PDT in treating head and neck cancer (Journal of Investigative and Clinical Dentistry, PMID 28480637; Oral Oncology, PMID 26865261; Photodiagnosis and Photodynamic Therapy, PMID 26072296, PMID 25917042).
Low-level laser therapy uses a low-power laser to remove tissue. Researchers are studying low-level laser as an alternative to radiation therapy to prevent sore mouth (mucositis), which is a common side effect of chemoradiation (Oral Oncology, PMID 26559740).
Radiofrequency and microwave ablation uses high-frequency electrical waves to create heat to destroy cancer cells. It may be a promising alternative treatment to standard therapy for recurrent or advanced head and neck cancers (Journal of Vascular and Interventional Radiology, PMID 26210246).
Learn more about cancer research @(Model.HeadingTag)>
Researchers continue to try to find out more about head and neck cancer. Clinical trials are research studies that test new ways to treat head and neck cancer. They also look at ways to prevent, find and manage cancer.
Clinical trials provide information about the safety and effectiveness of new approaches to see if they should become widely available. Most of the standard treatments for head and neck cancer were first shown to be effective through clinical trials.
Find out more about clinical trials.